|
AGBL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.582200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.419580E-01 |
| Normal-vs-Stage2 |
4.568400E-01 |
| Normal-vs-Stage3 |
7.843000E-01 |
| Normal-vs-Stage4 |
8.313800E-01 |
| Stage1-vs-Stage2 |
9.977400E-01 |
| Stage1-vs-Stage3 |
6.146400E-01 |
| Stage1-vs-Stage4 |
4.770200E-01 |
| Stage2-vs-Stage3 |
7.113400E-01 |
| Stage2-vs-Stage4 |
5.241000E-01 |
| Stage3-vs-Stage4 |
7.345600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.245000E-01 |
| Normal-vs-AfricanAmerican |
6.109600E-01 |
| Normal-vs-Asian |
3.250800E-01 |
| Caucasian-vs-AfricanAmerican |
8.331000E-01 |
| Caucasian-vs-Asian |
2.899600E-01 |
| AfricanAmerican-vs-Asian |
2.054400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.573700E-02 |
| Normal-vs-Female |
1.798600E-01 |
| Male-vs-Female |
6.742900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.053700E-02 |
| Normal-vs-Extreme_Weight |
1.854430E-02 |
| Normal-vs-Obese |
8.934200E-01 |
| Normal-vs-Extreme_Obese |
8.512000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.786400E-01 |
| Normal_Weight-vs-Obese |
8.317900E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.259600E-01 |
| Extreme_Weight-vs-Obese |
4.647900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.919400E-01 |
| Obese-vs-Extreme_Obese |
7.736000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.000000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.403400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.318650E-01 |
| Normal-vs-Age(81-100Yrs) |
6.628300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.409400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.084000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.216600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.403160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.299610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.163800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.295000E-01 |
| Normal-VS-Type2 PRCC |
2.098200E-01 |
| Normal-VS-KIRP CIMP |
5.519800E-01 |
| Normal-VS-Unclassified PRCC |
5.400800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.860200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.241800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.457600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.515200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.746240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.492600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.715400E-03 |
| Normal-vs-N1 |
5.599800E-01 |
| Normal-vs-N2 |
5.715800E-01 |
| N0-vs-N1 |
6.551700E-02 |
| N0-vs-N2 |
1.565160E-01 |
| N1-vs-N2 |
8.628800E-01 |
|
|
